What is the optimal glucose-lowering therapy in the two commonest subtypes of syndromic diabetes: HNF1B-diabetes and Mitochondrial Diabetes (MD) due to m.3243 A > G in the MT-TL1 gene? This evidence concerns the gene HNF1B and diabetes mellitus.